1. Home
  2. WVE vs MLCO Comparison

WVE vs MLCO Comparison

Compare WVE & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$13.40

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$6.24

Market Cap

2.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
MLCO
Founded
2012
2004
Country
Singapore
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
WVE
MLCO
Price
$13.40
$6.24
Analyst Decision
Strong Buy
Buy
Analyst Count
16
6
Target Price
$29.94
$9.42
AVG Volume (30 Days)
4.0M
2.1M
Earning Date
03-03-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$109,230,000.00
$5,061,044,000.00
Revenue This Year
N/A
$13.56
Revenue Next Year
$16.20
$2.49
P/E Ratio
N/A
$24.75
Revenue Growth
103.75
11.46
52 Week Low
$5.28
$4.55
52 Week High
$21.73
$10.15

Technical Indicators

Market Signals
Indicator
WVE
MLCO
Relative Strength Index (RSI) 43.21 30.46
Support Level $13.22 $5.90
Resistance Level $14.51 $6.40
Average True Range (ATR) 1.33 0.26
MACD -0.38 -0.04
Stochastic Oscillator 3.18 21.86

Price Performance

Historical Comparison
WVE
MLCO

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.

Share on Social Networks: